Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders

NCT00870727 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Pervasive Developmental Disorder

Interventions

DRUG: Aripiprazole oral product
DRUG: Placebo oral capsule

Sponsor

Indiana University

Collaborators

[object Object]
[object Object]